Zydus finalises patent agreement with Upsher-Smith Labs
Shital Jibhe / 13 Jan 2017
Zydus Pharmaceuticals (USA) Inc., a subsidiary of global pharmaceutical company Cadila Healthcare Ltd, today announced that it has finalised an agreement with Upsher-Smith Laboratories, Inc. to settle the patent litigation with reference to Qudexy capsules.
Zydus Pharmaceuticals (USA) Inc., a subsidiary of global pharmaceutical company Cadila Healthcare Ltd, today announced that it has finalised an agreement with Upsher-Smith Laboratories, Inc. to settle the patent litigation with reference to Qudexy capsules.
Cadila Healthcare is the fourth largest pharmaceutical company in India with an annual revenue of Rs 5,470 crore. The company has its headquarters at Ahmedabad in Gujarat,
The company's stock is up by 0.30 per cent and is currently trading at Rs 350.70. The stock has underperformed the BSE Sensex but outperformed the BSE Healthcare index over a period of one year.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.